×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BFRI – biofrontera inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BFRI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
09:00 am
bfri
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
Medium
Report
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
12/2
09:06 am
bfri
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT [Yahoo! Finance]
Low
Report
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT [Yahoo! Finance]
12/2
08:45 am
bfri
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
Low
Report
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
11/14
12:15 pm
bfri
Biofrontera (NASDAQ:BFRI) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Medium
Report
Biofrontera (NASDAQ:BFRI) had its "buy" rating reaffirmed by analysts at Benchmark Co..
11/13
11:53 am
bfri
Biofrontera Inc. (BFRI) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Biofrontera Inc. (BFRI) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/13
08:15 am
bfri
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
Medium
Report
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
11/7
08:00 am
bfri
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
High
Report
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
11/6
04:01 pm
bfri
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
Medium
Report
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/13
08:31 am
bfri
Form 8-K Biofrontera Inc. For: Nov 13
Medium
Report
Form 8-K Biofrontera Inc. For: Nov 13
11/12
04:31 pm
bfri
Form 10-Q Biofrontera Inc. For: Sep 30
Medium
Report
Form 10-Q Biofrontera Inc. For: Sep 30
11/12
02:53 pm
bfri
Form SCHEDULE 13G/A Biofrontera Inc. Filed by: Rosalind Advisors, Inc.
Medium
Report
Form SCHEDULE 13G/A Biofrontera Inc. Filed by: Rosalind Advisors, Inc.
11/10
04:31 pm
bfri
Form 8-K Biofrontera Inc. For: Nov 04
Low
Report
Form 8-K Biofrontera Inc. For: Nov 04
11/7
08:06 am
bfri
Form 8-K Biofrontera Inc. For: Nov 06
High
Report
Form 8-K Biofrontera Inc. For: Nov 06
10/24
05:29 pm
bfri
Form 8-K Biofrontera Inc. For: Oct 20
Medium
Report
Form 8-K Biofrontera Inc. For: Oct 20
10/23
08:50 am
bfri
Form 8-K Biofrontera Inc. For: Oct 23
High
Report
Form 8-K Biofrontera Inc. For: Oct 23
9/30
08:53 am
bfri
Form 3 Biofrontera Inc. For: Sep 16 Filed by: Link Christian Alexander Ansgar
Low
Report
Form 3 Biofrontera Inc. For: Sep 16 Filed by: Link Christian Alexander Ansgar
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: